Children above 15 to get Bharat Biotech's Covaxin only, for now

The Centre is of the opinion that booster shots are population- and frequency-specific interventions

As India’s adolescents queue up for their Covid shots on January 3, they have only one option available right now — Bharat Biotech-made Covaxin. Cadila Healthcare-developed deoxyribonucleic acid (DNA) vaccine ZyCoV-D — approved by the drug regulator for use in children aged 12 and above — will not be used right away to vaccinate youngsters aged 15 and above, claimed sources.

Government sources indicated the National Technical Advisory Group on Immunisation in India has not recommended the use of ZyCoV-D for the time being for children below 18. “Even after the Drugs Controller General of India (DCGI) approved the DNA